The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
US9290456, 67 ID: ALA3978036
PubChem CID: 71270264
Max Phase: Preclinical
Molecular Formula: C13H9F5N2O2
Molecular Weight: 320.22
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: O=c1[nH]nc(CCc2cc(F)c(C(F)(F)F)c(F)c2)cc1O
Standard InChI: InChI=1S/C13H9F5N2O2/c14-8-3-6(4-9(15)11(8)13(16,17)18)1-2-7-5-10(21)12(22)20-19-7/h3-5H,1-2H2,(H,19,21)(H,20,22)
Standard InChI Key: WNDBVELSJXWVGU-UHFFFAOYSA-N
Molfile:
RDKit 2D
22 23 0 0 0 0 0 0 0 0999 V2000
2.3383 -1.3500 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.2990 -0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2990 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 0.7500 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 -0.7500 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 -1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 -2.7000 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-0.0031 3.0008 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.3039 3.7494 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.3070 5.2502 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.6061 6.0003 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.6061 7.5003 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.6454 8.1002 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
-1.3071 8.2503 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.0080 7.5003 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0312 8.1004 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
-0.0080 6.0003 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.3071 9.7511 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.3460 10.3518 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
-0.2677 10.3508 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
-1.3066 10.9511 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 2 0
3 4 1 0
4 5 2 0
5 6 1 0
6 7 1 0
7 2 1 0
7 8 2 0
4 9 1 0
9 10 1 0
10 11 1 0
11 12 2 0
12 13 1 0
13 14 1 0
13 15 2 0
15 16 1 0
16 17 1 0
16 18 2 0
18 11 1 0
15 19 1 0
19 20 1 0
19 21 1 0
19 22 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 320.22Molecular Weight (Monoisotopic): 320.0584AlogP: 2.56#Rotatable Bonds: 3Polar Surface Area: 65.98Molecular Species: NEUTRALHBA: 3HBD: 2#RO5 Violations: ┄HBA (Lipinski): 4HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 6.91CX Basic pKa: ┄CX LogP: 2.90CX LogD: 2.28Aromatic Rings: 2Heavy Atoms: 22QED Weighted: 0.85Np Likeness Score: -0.65
References 1. (2016) Pyridazinone compounds and their use as DAAO inhibitors, 2. Raje, Mithun and 9 more authors. 2013-07-01 Synthesis of kojic acid derivatives as secondary binding site probes of D-amino acid oxidase. [PMID:23683589 ] 3. Hin, Niyada and 10 more authors. 2015-09-24 6-Hydroxy-1,2,4-triazine-3,5(2H,4H)-dione Derivatives as Novel D-Amino Acid Oxidase Inhibitors. [PMID:26309148 ] 4. Hin, Niyada and 8 more authors. 2016-04-15 D-Amino acid oxidase inhibitors based on the 5-hydroxy-1,2,4-triazin-6(1H)-one scaffold. [PMID:26965861 ] 5. Kato, Yusuke and 9 more authors. 2018-11-05 Structural basis for potent inhibition of d-amino acid oxidase by thiophene carboxylic acids. [PMID:30265959 ]